VGMIF yields 1333.33% · PFE yields 6.13%● Live data
📍 VGMIF pulled ahead of the other in Year 1
Combined, VGMIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VGMIF + PFE for your $10,000?
Visible Gold Mines Inc. acquires and explores for gold mineral deposits in Canada. The company holds a 100% interest in the Cadillac project comprising 145 mining claims covering approximately 5,000 hectares located in west of Rouyn-Noranda, Québec; the Piko property covering 26 mining claims situated in Abitibi-Témiscamingue in Québec; and the Veronik gold property that consists of 78 mining claims located in southeast of Hecla's Casa Berardi gold mine. In addition, it holds interest in the Horsefly Property with 175 mining claims covering an area of 6,050 hectares located in the Druillettes and Gradis townships; the Doda project that consists of 25 mining claims covering an area of approximately 1,400 hectares located in Québec; the Dovercliff property, which consists of 3 mining claims located in the Rouyn-Noranda, Québec; and the Phooey Lake property, which include 75 mining claims located in the Chibougamau, Québec. The company also holds a 100% interest in the MegaLi Project consisting of 78 mining claims covering an area of 3,996 hectares; and the NataLi Project comprising of 107 mining claims covering an area of 5,667 hectares located in the region of James Bay, Québec. Visible Gold Mines Inc. was incorporated in 2007 and is based in Rouyn-Noranda, Canada.
Full VGMIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.